Genomed Spólka Akcyjna (WSE:GEN)

Poland · Delayed Price · Currency is PLN

30.00

0.00 (0.00%)

At close: Aug 13, 2026

Genomed Spólka Akcyjna Financials Overview

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	29.58	29.12	23.01	22.48	20.46	19.89
Revenue Growth	21.90%	26.58%	2.34%	9.88%	2.84%	6.08%
Gross Profit	19.52	19.33	14.49	14.11	12.18	12.55
Operating Income	3.86	4.08	1.2	1.24	0.36	1.34
Net Income	3.07	3.4	1.11	0.93	0.34	1.24
Earnings Per Share	2.32	2.57	0.84	0.70	0.26	0.94
EPS Growth	56.81%	207.58%	19.32%	174.07%	-72.70%	200.29%

Revenue by Segment

Fiscal Year	TTM	FY 2025
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025
Sales of Products	29	28.52
Sales of Goods and Materials	0.58	0.6
Total	29.58	29.12

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	5.53	6.1	5.24	5.26	3.49	4.86
Total Debt	-	-	-	-	-	-
Net Cash (Debt)	5.53	6.1	5.24	5.26	3.49	4.86
Net Cash Growth	15.36%	16.37%	-0.37%	50.81%	-28.21%	34.03%
Net Cash Per Share	4.18	4.62	3.97	3.98	2.64	3.68

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	3.28	3.23	1.64	1.97	-0.36	2.21
Capital Expenditures	-1.43	-1.13	-1.67	-0.2	-0.25	-0.52
Free Cash Flow	1.86	2.11	-0.03	1.76	-0.6	1.7
Free Cash Flow Growth	13.16%	-	-	-	-	91.94%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	65.99%	66.36%	63.00%	62.75%	59.52%	63.09%
Operating Margin	13.05%	14.01%	5.23%	5.53%	1.74%	6.72%
Pretax Margin	12.97%	13.99%	5.27%	4.68%	1.80%	6.70%
Profit Margin	10.38%	11.67%	4.80%	4.12%	1.65%	6.22%
FCF Margin	6.28%	7.24%	-0.12%	7.84%	-2.94%	8.52%

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Aug '26 Aug 16, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	1.500	1.500
Dividend Per Share Growth	0%	-
Dividend Yield	5.07%	6.54%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.73	9.41	31.80	42.51	132.93	36.50
P/FCF Ratio	21.05	15.17	-	22.33	-	26.65
PS Ratio	1.32	1.10	1.53	1.75	2.20	2.27